Page last updated: 2024-08-21

quinazolines and Thoracic Neoplasms

quinazolines has been researched along with Thoracic Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heymach, JV; Nikolinakos, P	1
Abrams, DI; Cheng, J; Dhruva, A; Kwong, M; Luce, JA	1
Ebi, H; Fujisaka, Y; Horiike, A; Jiang, H; Kawada, K; Minami, H; Murakami, H; Saijo, N; Sasaki, Y; Shimoyama, T; Shinkai, T; Tahara, M; Tamura, T; Yamada, Y; Yamamoto, N	1
Burkitt, V	1

Reviews

1 review(s) available for quinazolines and Thoracic Neoplasms

Article	Year
The tyrosine kinase inhibitor cediranib for non-small cell lung cancer and other thoracic malignancies. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:6 Suppl 2 Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Disease Models, Animal; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Protein-Tyrosine Kinases; Quinazolines; Risk Assessment; Survival Analysis; Thoracic Neoplasms	2008

Article

Year

The tyrosine kinase inhibitor cediranib for non-small cell lung cancer and other thoracic malignancies.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:6 Suppl 2

Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Disease Models, Animal; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Protein-Tyrosine Kinases; Quinazolines; Risk Assessment; Survival Analysis; Thoracic Neoplasms

2008

Trials

1 trial(s) available for quinazolines and Thoracic Neoplasms

Article	Year
A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:9 Topics: Administration, Oral; Adult; Aged; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Japan; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Piperidines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Risk Assessment; Survival Analysis; Thoracic Neoplasms; Treatment Outcome	2006

Article

Year

A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:9

Topics: Administration, Oral; Adult; Aged; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Japan; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Piperidines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Risk Assessment; Survival Analysis; Thoracic Neoplasms; Treatment Outcome

2006

Other Studies

2 other study(ies) available for quinazolines and Thoracic Neoplasms

Article	Year
Contrasts, conflicts, and change: A case in cultural oncology. The journal of supportive oncology, 2006, Volume: 4, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Attitude to Health; Carboplatin; Cultural Characteristics; Erlotinib Hydrochloride; Family Relations; Female; Humans; Middle Aged; Paclitaxel; Physician-Patient Relations; Quinazolines; Thoracic Neoplasms	2006
In Australia, patients and government at odds over mesothelioma treatment costs. Journal of the National Cancer Institute, 2007, Dec-05, Volume: 99, Issue:23 Topics: Abdominal Neoplasms; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Australia; Canada; Carcinogens; Cisplatin; Cost-Benefit Analysis; Environmental Exposure; Glutamates; Government; Guanine; Health Care Costs; Humans; Incidence; Lobbying; Lung Neoplasms; Mesothelioma; Patient Advocacy; Pemetrexed; Quinazolines; Thiophenes; Thoracic Neoplasms; United Kingdom	2007

Article

Year

Contrasts, conflicts, and change: A case in cultural oncology.

The journal of supportive oncology, 2006, Volume: 4, Issue:6

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Attitude to Health; Carboplatin; Cultural Characteristics; Erlotinib Hydrochloride; Family Relations; Female; Humans; Middle Aged; Paclitaxel; Physician-Patient Relations; Quinazolines; Thoracic Neoplasms

2006

In Australia, patients and government at odds over mesothelioma treatment costs.

Journal of the National Cancer Institute, 2007, Dec-05, Volume: 99, Issue:23

Topics: Abdominal Neoplasms; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Australia; Canada; Carcinogens; Cisplatin; Cost-Benefit Analysis; Environmental Exposure; Glutamates; Government; Guanine; Health Care Costs; Humans; Incidence; Lobbying; Lung Neoplasms; Mesothelioma; Patient Advocacy; Pemetrexed; Quinazolines; Thiophenes; Thoracic Neoplasms; United Kingdom

2007